![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 28, 21422-21428, July 14, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
¶
From the
Division of Biochemistry and Molecular
Biology, University of California, Berkeley, California 94720-3202 and the § Department of Cell Genetics, Institute of
Molecular Embryology and Genetics, Kumamoto University School of
Medicine, Kumamoto 862-0976, Japan
Received for publication, February 4, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Damage-specific DNA binding (DDB) activity
purifies from HeLa cells as a heterodimer (p127 and p48) and is absent
from cells of a subset (Ddb The rare human hereditary disease, xeroderma pigmentosum
(XP),1 is characterized
biochemically by defective nucleotide excision repair (NER), which
manifests clinically as sensitivity to ultraviolet light and a high
incidence of skin cancer. Based on fusion studies of cells from XP
patients, seven NER-defective complementation groups (A through G) and
a post-replication repair-deficient variant group (XPV) have been
identified (1, 2). Cell strains from a subset (Ddb In the present study, we have reconstituted human DDB activity in an
electrophoretic mobility shift assay by combining insect extracts
containing individually overexpressed wild type p127 and p48. Both
extracts were required for damage-specific DNA binding activity, but
extracts containing mutant XP2RO- and XP82TO-p48 polypeptides were
unable to complement p127, demonstrating that the mutations inactivate
DDB activity in these XPE Ddb Cultures and Strains--
Sf9 insect cells, HeLa cells,
and IMR-90 and XPE fibroblast strains were cultured as described
previously (10, 18). The fibroblast XPE strain GM01389 was obtained
from the Coriell Institute cell repository (Camden, NJ).
Constructs for Overexpression of Mutant p48 in Insect
Cells--
To construct the mutant XP2RO DDB2 transfection vector, a
reverse transcription-polymerase chain reaction (PCR) product (18), containing cDNA nucleotides +820 to +1724 of XP2RO DDB2, was
digested with BsmI and ApaI. This restriction
fragment (nucleotides +898 to +1690), containing the G
Transfection of Sf9 cells, plaque selection, recombinant virus
amplification, infection, and harvesting of cells was carried out
according to the BacPAK Expression System protocol
(CLONTECH). 7.5 × 106 Cells were
infected with a multiplicity of infection of 5, and the surviving
4 × 106 cells were harvested 66 h postinfection,
resuspended in 300 µl of 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM dithiothreitol (DTT), and lysed
by sonication. The lysate was clarified by centrifugation for 15 min at
19,000 × g prior to gel analysis and assay.
Overexpression and Purification of DDB p127--
The purity of
fractions was monitored by analysis on SDS-polyacrylamide gel
electrophoresis (PAGE) followed by Brilliant Blue-G colloidal staining
(Sigma). Activity was detected through reconstitution of DDB activity
in an electrophoretic mobility shift assay (EMSA) by complementing p127
fractions with p48. The p48 was overexpressed in Sf9 cells, and
1 µg of the clarified extract was added to each reaction.
To construct the DDB1/p2Bac transfection vector, PCR was used to insert
the insect Kozak sequence, GCCACC, immediately 5' of the wild type ATG
start codon of the DDB1 cDNA coding sequence. An XbaI
and a SacII site were created by PCR at nucleotides
To purify p127, 3 × 108 Sf9 cells in 300 ml of
EX-CELL 400 (JRH BioSciences, Lenexa, KS) with 2% fetal bovine serum
and 1% Fungizone (Life Technologies, Inc.) were transfected with
DDB1/p2Bac at a multiplicity of infection of 5. After 48 h in
spinner flasks at 27 °C, the cells were harvested, resuspended in 15 ml of lysis buffer (57 mM potassium phosphate (pH 7.5), 1 mM DTT, 0.2 mM phenylmethylsulfonyl fluoride),
and lysed by sonication. Glycerol was then added to 10% (v/v), and the
lysate was clarified by centrifugation for 15 min at 19,000 × g. The supernatant was loaded onto a 30-ml Whatman P11
phosphocellulose column pre-equilibrated with 50 mM PDG
(potassium phosphate (pH 7.5), 1 mM DTT, 10% glycerol),
and then the column was washed with 40 ml of PDG. Those fractions containing active p127 were pooled and loaded onto a 7-ml Amersham Pharmacia Biotech DEAE-Sephacel column pre-equilibrated with 50 mM PDG, and then the column was washed with 11 ml of PDG
and eluted with a 35-ml linear gradient of 50-600 mM
potassium phosphate in 1 mM DTT, 10% glycerol. Active p127
eluting between 125 and 165 mM phosphate was concentrated
to 0.7 ml with a Centricon 30 filter (Amicon) and loaded onto a 120-ml
6.0- × 60-cm S300 column (Amersham Pharmacia Biotech), which was
developed with 100 mM PDG. Active p127 eluted between 0.5 and 0.6 column volumes.
Overexpression and Purification of DDB p48--
The
DDB2/pBakPAK8 vector used for the overexpression of p48 in Sf9
cells has been previously described (18). Purification was monitored by
analysis on SDS-PAGE, and activity complementation was measured with 21 ng (165 fmol) of purified p127.
3 × 108 Sf9 cells in 300 ml of EX-CELL 400 with 2% fetal bovine serum and 1% Fungizone were transfected with
DDB2/pBacPAK8 at a multiplicity of infection of 10. After 48 h in
spinner flasks at 27 °C, the cells were harvested, resuspended in 15 ml of 57 mM potassium phosphate (pH 7.5)/1 mM
DTT and lysed by sonication. Glycerol was added to 10% (v/v), and the
lysate was clarified by centrifugation for 15 min at 19,000 × g. The pellet was extracted twice by resuspension in 15 ml
of lysis buffer, sonication, adjustment to 10% glycerol, and
centrifugation as above.
The combined supernatant was loaded onto a 30-ml phosphocellulose
column pre-equilibrated with 50 mM potassium phosphate (pH 7.5), 10% glycerol, 1 mM DTT. The column was washed with
60 ml of the same buffer and then eluted with a 150-ml linear gradient from 50 to 1000 mM PDG. The p48 activity eluting between
350 and 400 mM phosphate was dialyzed against loading
buffer and then loaded onto a 3-ml DEAE-Sephacel column
pre-equilibrated with the same buffer. The column was washed with 6 ml
of loading buffer and then eluted with a 20-ml linear gradient from 50 to 600 mM potassium phosphate in glycerol/DTT. The p48
activity, which eluted at 100 mM phosphate, was
concentrated to 0.8 ml in a Centricon 10 filter (Amicon) and loaded
onto a 24-ml 1.0- × 30-cm Superose6 column (Amersham Pharmacia
Biotech) equilibrated with 100 mM potassium phosphate (pH
7.5), 1 mM DTT, 10% glycerol. The column was developed with the same buffer, and 0.4-ml fractions were collected. p48 activity
eluted at fractions corresponding to a molecular weight of 41,400 relative to Bio-Rad standards (catalogue no. 151-1901).
Reconstitution of DDB Activity in an EMSA--
Fractions of p127
and p48 were incubated in 25 mM Tris-HCl (pH 8.0), 5%
glycerol, 5 mM MgCl2, 60 mM KCl,
0.1 mg/ml bovine serum albumin, and 5 nmol of poly(dI-dC) (nucleotide
residues) (Midland Certified Reagent). After 15 min at room
temperature, 8 fmol of 32P-labeled 77-base pair double
stranded DNA, UV-irradiated with 6 kJ/m2, was added, and
the reaction was incubated for an additional 15 min at 30-32 °C.
Samples were electrophoresed on 5% polyacrylamide gels in Tris
borate/EDTA buffer, and the dried gels were exposed to x-ray film or
scanned using a Molecular Dynamics PhosphorImager. One unit of DDB
activity is defined as that amount forming 1 fmol of DDB·DNA complex.
Sequence Analysis of DDB1 and DDB2 in GM01389--
Mutation
analysis of cDNA was performed as described previously (22);
cDNA produced by reverse transcription-PCR was sequenced for both
DDB1 (p127) and DDB2 (p48). Genomic DNA was amplified by PCR using the
primers: I-580, 5'-GTGGGTTTCCTTCTCTTTTT-3', and 1302, 5'-CATCTTCCCTGAGTTTCCAT-3'. Then the genomic DNA PCR products were
cloned into a pGEM-T Easy Vector (Promega), and the clones were
sequenced using the primer I-333, 5'-ATTAGGTTGGCTTGTTACTG-3', to
analyze for mutations in DDB2 at nucleotides +1045 to +1047 and
nucleotide +1049.
Analysis of DDB Activity after UV Irradiation--
1.0 × 106 IMR-90 fibroblasts were seeded onto 150-mm culture
plates in 30 ml of Dulbecco's modified essential medium (Life Technologies, Inc.) with 10% fetal bovine serum. After incubation for
4 days at 37 °C in 5% CO2, the medium was aspirated off
and replaced with 4 ml of cold phosphate-buffered saline (PBS) and the
monolayer of subconfluent cells was irradiated with 12 J/m2
254-nm light. The PBS was then replaced with 30 ml of fresh culture medium, and the cells were returned to the incubator until harvest. Three to four plates were harvested at each time point: the cells were
washed with PBS, layered with 4 ml of 0.05% trypsin/0.53 mM EDTA per plate, incubated at 37 °C for 20 min, and
then 4 ml of fresh medium was added. The detached cells were pelleted,
washed with PBS, and resuspended in a total volume of 15 ml of PBS of which 12 ml was pelleted for cell-free extract and 3 ml was pelleted for RNA isolation (see below). Extract was prepared by resuspending the
cells in 400 µl of lysis buffer (50 mM potassium
phosphate (pH 7.5), 10% glycerol, 1 mM DTT), lysing by
sonication, and clarifying the lysate by centrifugation for 15 min at
19,000 × g. DDB activity was monitored by EMSA as
described above using 1.5 or 5 µg of extract, rather than the
individual subunits.
Analysis of p48 mRNA Levels by Quantitative Competitive
Reverse Transcription-PCR--
To prepare competitive RNA, the DDB2
cDNA sequence from nucleotides +872 to +1196, with a deletion from
+891 to +939, was inserted into a pT7-7 vector immediately 3' of the T7
promoter. RNA was synthesized as per the Promega T7 RNA polymerase
protocol using 1 µg of linearized plasmid template, 20 units of RNase
inhibitor (Life Technologies, Inc.), a 0.5 mM concentration
of each rNTP, and 10 units of T7 RNA polymerase. The RNA was treated
with 10 units of DNase I (Amersham Pharmacia Biotech) and purified with an RNeasy Mini Kit (Qiagen). Total RNA was isolated from cell pellets
of the UV-irradiated IMR-90 cells (see above) with an RNeasy Mini Kit.
cDNAs used for each PCR reaction were reverse-transcribed from 50 ng of IMR-90 total RNA and a range of 2,500 to 50,000 copies of
competitive p48 RNA using a reverse primer from the DDB2 sequence +1171
to +1152. The same reverse primer and a forward primer from +872 to
+890 were used for the PCR reaction. Conditions for quantitating p48
mRNA levels by quantitative competitive reverse transcription-PCR
(QC-RT-PCR) were essentially as described by Borson et al.
(23), except that PCR primers were 5'-end labeled with 32P,
and the PCR products were resolved on a 5% native polyacrylamide gel
and analyzed with a PhosphorImager (Molecular Dynamics) using ImageQuaNTTM 1.2. The number of copies of p48 mRNA was calculated on the assumption that there are 25 pg of total RNA in a single eukaryotic cell (Qiagen RNeasy protocol).
Production of Polyclonal Antibodies against p48 and
Immunoblotting--
His6-tagged human p48 protein was
overexpressed in Escherichia coli from the
His6-tagged vector, pET29b (Novagen). Polyclonal antibodies
were raised in rabbits against the affinity-purified recombinant
His6-p48 protein, and IgG was purified from serum by
ammonium sulfate precipitation and protein A column purification (HiTrap protein A; Amersham Pharmacia Biotech).
Analysis of DDB p48 Protein after UV Irradiation--
0.5 × 106 IMR-90 cells were seeded onto 100-mm culture plates
in 10 ml of Dulbecco's modified essential medium (Life Technologies, Inc.) supplemented with 15% fetal bovine serum and incubated at 37 °C in 5% CO2. When the cells reached early- to
mid-log phase, the medium was aspirated off and replaced with cold PBS,
and the monolayer of subconfluent cells was irradiated with 12 J/m2 254-nm light. The PBS was then replaced with fresh
culture medium, and the cells were returned to the incubator until
harvest. Eight plates were harvested at each time point. Whole cell
extracts were prepared as follows. The cell pellet was resuspended in
200 µl of hypotonic buffer (10 mM Tris-HCl, pH 8.0, 5 mM MgCl2, and protease inhibitors (Complete;
Roche Molecular Biochemicals). After 15 min, the cells were lysed by 50 strokes in a Dounce homogenizer. Potassium glutamate buffer (250 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 0.3 M potassium glutamate (pH 7.8), 5 mM DTT, 50%
glycerol, and protein inhibitors) was added, and the extract was
incubated for 30 min with occasional gentle mixing. The extract was
clarified by ultracentrifugation for 1 h at 50,000 rpm
(106,000 × g) in a Beckman 100.3 rotor at 4 °C and
then dialyzed against 50 mM Tris-HCl (pH 8.0), 1 mM DTT, and 10% glycerol. 50 µg of extract was resolved
by 10% SDS-PAGE and transferred to nitrocellulose paper, and a
200-fold dilution of purified p48 antibody was used for immunoblotting.
Fluorescence Microscopy of DDB p48 Subcellular
Localization--
Full-length cDNAs for both wild type and mutant
DDB p48 were amplified by PCR with native Pfu DNA polymerase
(Stratagene) using primers 5'-AACGGATCCATGGCTCCCAAGAAAC-3' and
5'-TAGGGATCCTCACTTCCGTGTCCTGG-3', corresponding to cDNA nucleotides
DDB2 Mutations Inactivate UV-specific Binding of DDB in Cell-Free
Extracts--
DDB activity can be reconstituted in an EMSA by mixing
insect cell extracts containing individually overexpressed wild type p127 and p48 subunits (Fig. 1). Both
subunits are required to produce the DDB·DNA complex band formed by
the DDB heterodimer purified directly from HeLa cells (10).
The mutant p48 proteins, XP82TO-p48 and XP2RO-p48, containing the amino
acid substitutions K244E and R273H, respectively, were overexpressed in
a baculovirus-insect cell system (Fig.
2). The migration of XP2RO-p48 with a
Mr of 41,000 is unchanged from that of wild type
p48, whereas the single amino acid substitution in XP82TO results in an
aberrant migration at a Mr of 42,500. SDS-PAGE
comparing the quantity recovered from whole cell and clarified extracts
showed no significant difference in expression or solubility between
the wild type and mutant p48 proteins (data not shown). When the
Sf9 extracts containing overexpressed mutant p48 polypeptides
were mixed with the Sf9 extracts containing wild type p127 and
analyzed by EMSA, the specific human DDB band shift was absent,
demonstrating that the single mutations in both XP2RO and XP82TO are
sufficient to inactivate DDB activity (Fig. 1). This rules out an
alternative possibility that the DDB2 mutations in these cell strains
are not responsible for the Ddb Purification of Wild Type Human p127 and p48 Overexpressed in
Insect Cells--
Reconstitution of DDB activity in vitro
by mixing fractions containing the individual subunits as analyzed by
EMSA was used to monitor the purification of the p127 and the p48 DDB
subunits overexpressed in Sf9 cells. When overexpressed in a
baculovirus-insect cell system, human p127 is soluble and represents
20-25% of the protein in the clarified cell-free extract (Figs. 2 and
3A). This material was
purified by chromatography on phosphocellulose, DEAE-Sephacel, and
Sephacryl-S300 resins as described under "Experimental Procedures" and summarized in Table I. The final
material appears to be homogeneous and migrates at a
Mr of 127,000 as analyzed by SDS-PAGE followed by Brilliant Blue-G colloidal staining (Fig. 3A).
Although the p48 polypeptide was soluble in the cell-free extract, it
represented only 3-4% of the total cellular protein when
overexpressed (Figs. 2 and 3B). This material was purified by chromatography on phosphocellulose, DEAE-Sephacel, and Superose6 columns as described under "Experimental Procedures" and summarized in Table II. Because p48 eluted from the
Superose6 column at a position corresponding to a
Mr of 41,400, it would appear to be a monomer in
solution. This is consistent with its SDS-PAGE migration at 41,000 and
its predicted molecular weight of 47,966 based on the cDNA
sequence. The final material represented approximately 20% of the
total protein in the peak Superose6 fraction as analyzed by SDS-PAGE
(Fig. 3B). (The p48 polypeptide is the lower band of a
doublet that migrates at the anticipated Mr of
41,000.) We have not had evidence for p48 acting other than
stoichiometrically. For example, an estimated 0.2 fmol of p48 from the
peak Superose6 fraction and 165 fmol of DDB p127 formed approximately
0.2 fmol of the DDB-damaged DNA complex, indicating that p48 acted
stoichiometrically in the binding reaction, rather than catalytically.
As expected, increasing the amount of p48 increased the level of DDB
binding proportionately (data not shown).
Wild Type p48 Restores DDB Activity to Extracts from XPE
DDB-deficient GM01389 Cells--
Clarified extract prepared from
GM01389 diploid fibroblasts was deficient in DDB activity (Fig.
4), confirming the previously reported
identification of this strain as Ddb Maximum Increases in p48 mRNA Levels, p48 Protein, and DDB
Activity, Post-UV Irradiation, Are Observed after DNA Repair Is
Completed--
When early- to mid-log phase IMR-90 fibroblasts were
irradiated with 12 J/m2 UV light and harvested at various
times up to 72 h after treatment, cell survival reached a minimum
of 40% after 38 h (Fig.
5A), whereas p48 mRNA
levels reached a maximum at that same time (Fig. 5B). After
an initial level of 17 copies per unirradiated normal fibroblast, p48
mRNA levels peaked at 62 copies per cell at 38 h. This
increase in p48 mRNA levels preceded a similar peak in p48 protein
levels (Figs. 5C and 6) and
DDB activity (Fig. 5D) at 48 h post-UV. DNA repair,
however, is known to be essentially complete after 24 h post-UV
irradiation (25). Therefore, although induced almost 4-fold, this DDB
enhancement does not correlate with DNA repair. Moreover, because p127
is not induced (26), the correlation of p48 induction and activity
suggests that p48 is limiting for DDB activity in vivo and
that it acts stoichiometrically not catalytically. The level of DDB
activity and UV response in cell-free extracts from the early- to
mid-log phase XPE Ddb DDB2 Mutations in XPE Ddb Although the proteins correlated with XPA, XPB, XPC, XPD, XPF,
XPG, and XPV have been identified and studied, the XPE protein has
remained elusive. One contributing factor is that XPE patients exhibit
the mildest clinical signs of UV sensitivity and skin cancer of all the
xeroderma pigmentosum groups. This is reflected biochemically in that
cells from group E individuals have a relatively high level of
nucleotide excision repair as determined by an unscheduled DNA
synthesis level of 40-60%. Consequently, classification of XPE
patients has been difficult, and functional complementation of XPE has
not isolated the XPE gene.
In 1988 Chu and Chang (3) reported that a damage-specific DNA-binding
protein was absent in cells from two XPE patients, XP2RO and XP3RO.
However, further studies (4, 5) discovered only one additional XPE
strain, XP82TO, that lacked this binding activity, whereas cells from
13 other patients classified as XPE had normal levels of DDB activity.
Three additional XPE Ddb Cells from the XP2RO and XP3RO patients, who were second cousins, have
a single base transition that gives rise to a R273H substitution in
p48. A single base transition in XP82TO results in a K244E
substitution. No DDB2 mutations were observed in the XPE
Ddb+ strains, nor were any mutations found in the
DDB1 (p127) gene in any of the XPE strains investigated
(18). However, it remained possible that these DDB2 mutations were not
responsible for the Ddb In this report we have used functional assays to demonstrate that the
DDB2 mutations are directly responsible for the loss of DDB activity in
the XP2RO, XP3RO, and XP82TO Ddb The question still remains as to the function(s) of DDB in the cell.
The original proposal that DDB is a damage recognition factor in
nucleotide excision repair has yet to be substantiated. DDB is not
required in in vitro reconstitution DNA repair assays and
can even inhibit excision of damage (16). Possibly, the DDB heterodimer
inhibits repair in vivo so as to modulate the rate of
excision or allow damage bypass by a DNA polymerase. Because p48, but
not p127, is induced by DNA-damaging agents (26), we analyzed the time
response of p48 mRNA levels and DDB activity after UV irradiation
of normal diploid fibroblasts. p48 mRNA levels peaked at 38 h,
followed by a similar, almost 4-fold increase in DDB activity 48 h
after UV irradiation. However, these peaks occur after a majority of
DNA repair has been completed (25), suggesting an alternative role for
DDB. (It is feasible, though unlikely, that this late induction could
represent a replenishment of DDB once repair is complete and cell
division resumes.)
DDB p127 interacts with several viral transactivating proteins: protein
X of hepatitis B virus (30, 31), and the V proteins of paramyxovirus
SV5, mumps virus, human parainfluenza virus 2, and measles virus (32).
DDB can associate with the transcription factor, E2F1, and function as
a transcriptional partner of E2F1, whereas XP2RO and XP82TO p48 mutant
proteins are severely impaired in stimulating E2F1-activated
transcription (28). Watanabe and colleagues (33) reported that DDB p127
also binds to the cytoplasmic domain of the transmembrane protein,
Alzheimer's amyloid precursor protein (APP). They proposed that p127
may move between the cytosol and nucleus as part of a signal
transduction process that regulates gene transcription in response to
DNA damage. Because p48 transports p127 to the nucleus (28), a feasible
model is that excess p127 is anchored in the cytoplasm by binding to
APP. In response to damage, p48 mRNA levels increase, resulting in
increased production of p48 protein. This de novo p48 may
compete with APP for binding to p127 and transport it to the nucleus,
as reflected by the observed increase in DDB activity after UV
irradiation. XP2RO and XP82TO mutant p48 are defective in nuclear
import of the large DDB subunit (28).
Hwang et al. (34) reported that the presence of p48 was not
required for subsequent binding of p127 to DNA damage and that only a
small fraction of DDB was a heterodimer either in solution or bound to
DNA. Yet the DDB heterodimer is stable during purification (10), and in
this report we show elution characteristics during chromatography of
human p127 overexpressed alone in insect cells that are very different
from the heterodimer. Also DDB activity can be reconstituted only by
mixing purified p127 and p48, and p48 acts stoichiometrically in
binding to damaged DNA in vitro and apparently in
vivo. However, although the heterodimer produces a distinct DNase
I footprint on DNA substrates containing unique UV photoproducts (8),
the footprint for p127 alone indicates that both subunits need not be
bound to damaged DNA. Hence, it is possible that, if bound to p48, and
only after such binding, p127 can bind to DNA and remain bound even if
p48 dissociates. However, the correlation of p48 and DDB induction by
UV irradiation suggests that such a "catalytic" role for p48 may
not normally exist in vivo. We have shown that the single
base substitutions found in DDB2 of the XPE Ddb The abundance of DDB (~105 copies per cell: Ref 10 and
Fig. 5D) implies that DDB plays an important role in the
cell. Moreover, its specificity and high affinity for damaged DNA
suggests it has a role in DNA damage responses, but its late induction
after UV irradiation proposes alternative roles. The interacting
subunits of DDB may couple transcription to DNA damage by sensing such damage, whereas the individual DDB subunits perform different functions
in the cell. We expect that the purified individual DDB subunits will
allow us to study the function(s) of both the heterodimer and the
individual subunits in the multiple potential roles of DDB in
transcription, DNA damage responses, and DNA repair.
) of xeroderma
pigmentosum Group E (XPE) patients. Each subunit was overexpressed in
insect cells and purified. Both must be present for the damaged DNA
band shift characteristic of the HeLa heterodimer. However,
overexpressed p48 peptides containing the mutations found in three
Ddb
XPE strains are inactive, and wild type p48 restores
DDB activity to extracts from a fourth XPE Ddb
strain,
GM01389, in which compound heterozygous mutations in DDB2 (p48) lead to
a L350P change from one allele and a Asn-349 deletion from the other.
Although these results indicate that these mutations are each
responsible for the loss of DDB activity, they do not affect nuclear
localization of p48. In normal fibroblasts, a 4-fold increase in p48
mRNA amount was observed 38 h after UV irradiation, preceding
a similar elevation in p48 protein and DDB activity at 48 h,
implying that p48 limits DDB activity in vivo. Because DNA
repair is virtually complete before 48 h, a role for DDB other
than DNA repair is suggested.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) of
individuals carrying XP complementation group E (XPE) lack a
damage-specific DNA binding (DDB) activity (3-5). Because DDB was
reported to recognize many types of DNA lesions (6-11) and is
inducible by treatment with DNA-damaging agents (7, 12, 13), DDB was
originally expected to play a role in damage recognition prior to
nucleotide excision repair. However, recent NER reconstitution studies
have reported that DDB is not required in vitro (14-16). Nonetheless, microinjection of purified HeLa DDB heterodimer (p127, p48) into XPE cells restores in vivo DNA repair synthesis to
normal levels in XPE Ddb
strains but not in XPE
Ddb+ strains or in cells from other XP groups (17).
Sequencing of the cDNAs that encode the DDB heterodimer have
identified single base mutations only in DDB2 (p48) of XPE
Ddb
cells. In the Ddb
strains, XP2RO and
XP3RO, a G
A transition at nucleotide +818 causes an R273H change
in p48, whereas an A
G transition at nucleotide +730 causes a K244E
change in XP82TO. Overexpression of wild type p48, but not of p127, in
insect cells greatly increases DDB activity in extracts prepared from
these cells, indicating that p48 is required for damage-specific DNA
binding (18).
strains. The wild type
human p127 and p48, which were overexpressed in insect cells, were
purified by monitoring the reconstitution of DDB, and purified wild
type p48 was able to restore DDB activity to an extract prepared from a
fourth XPE Ddb
cell strain, GM01389. Mutations were
identified in the DDB2 gene in this strain. Because there
are three potential nuclear localization signals in the p48 sequence,
one of which is abolished by the mutation in XP82TO, fluorescence
microscopy was used to determine the cellular localization of wild type
and mutant p48. Finally, the relationships between DDB activity and p48
mRNA and protein levels in normal fibroblasts in response to UV
damage were analyzed. The accompanying paper (19) investigates the
cellular localization of p127 in both normal and XPE fibroblasts in
response to UV damage.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
A mutation
at +818, was ligated into pTB13 (wild type DDB2 cDNA in pBluescript
SK (20)), which had been digested with BsmI and
ApaI to remove the corresponding wild type cDNA region.
The resulting vector was digested with StuI, releasing the
XP2RO cDNA sequence
62 to +1317, which was inserted into pBacPAK8
(CLONTECH) at the StuI site to produce the transfection vector 2RO-p48/pBacPAK8. To construct the mutant XP82TO DDB2 transfection vector, the A
G mutation at nucleotide +730 was introduced into the wild type DDB2 cDNA sequence by
overlap extension PCR (21). Then the mutant DDB2 cDNA, containing
nucleotides
11 to +1317, was inserted into pBacPAK8 at the
BamHI and StuI sites to produce the transfection
vector 82TO-p48/pBacPAK8.
10 and
+3425 (immediately 3' of the wild type stop codon), respectively. This
fragment, which contained the entire DDB1 cDNA coding sequence, was
inserted into the p2Bac baculovirus vector (Invitrogen) at the
XbaI and SacII restriction sites to yield
DDB1/p2Bac.
12 to +16 and +1268 to +1293, respectively. The PCR products were
digested with BamHI and then cloned into the mammalian
expression vector pEGFP-C1 (CLONTECH). The
pEGFP-p48, pEGFP-p48RO, and pEGFP-p48TO, correspond to GFP-p48 wild
type, XP2RO, and XP82TO mutants, respectively. To express the GFP-p48
proteins, exponentially growing IMR-90 cells at passage eight were
seeded into 6-well plates (35 mm) with glass coverslips at 2.5 × 105 cells per well and incubated at 37 °C in 5%
CO2. After 24 h, the cells were transfected with the
control vector pEGFP-N3, or the pEGFP-DDB p48 expression vectors, using
the Fugene-6 transfection reagent (Roche Molecular Biochemicals)
according to the manufacturer's guidelines. 24 h after
transfection, the cells were fixed with cold 2% paraformaldehyde at
4 °C for 30 min and then stained with 0.1 µg/ml
4',6-diamidino-2-phenylindole (DAPI, Sigma) at room temperature for 30 min. Coverslips were mounted in 22% glycerol, 9% Mowiol, 0.06%
n-propyl-gallate, 90 mM Tris-HCl, pH 8.0, and sealed with rubber cement. Fluorescence microscopy was performed on a
Zeiss Axiophot at 40× resolution with appropriate filters for GFP and
DAPI.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (41K):
[in a new window]
Fig. 1.
Wild type, but not XP82TO or XP2RO, p48
complement p127 in vitro. Binding of overexpressed human
protein from clarified insect extracts to 32P-labeled DNA
substrate was monitored by the electrophoretic mobility shift assay
described under "Experimental Procedures" and visualized using a
PhosphorImager (Molecular Dynamics). Lanes 1 and
2, DDB heterodimer (p48 + p127) partially purified from HeLa
cells; lanes 3 and 4, mixtures of individually
overexpressed wild type p48 and p127; lanes 5-8, mixtures
of individually overexpressed mutant p48 and wild type p127;
lanes 9 and 10, wild type p127; lanes
11 and 12, wild type p48; lanes 13-16,
mutant p48; lanes 17 and 18, uninfected
Sf9 insect cell extract. Abbreviations used are: WT,
overexpressed human wild type subunit p48 or p127; TO,
overexpressed human mutant XP82TO-p48; RO, overexpressed
human mutant XP2RO-p48; Sf9, the positions of bands
due to UV-specific background insect (Sf9) protein-DNA complexes
as indicated to the side of the gel; DDB, the
positions of the bands due to HeLa DDB. The two bands unique to
HeLa-derived DDB or complemented subunits are due to 1 or 2 DDB
molecules binding the damaged oligonucleotide (18).
phenotype and that a
third (unidentified) subunit of DDB could be defective in all XPE
strains.

View larger version (35K):
[in a new window]
Fig. 2.
Overexpression of p48 and p127 DDB subunits
in Sf9 cells. Clarified extracts containing the indicated
overexpressed DDB subunits were electrophoresed on a 7-12%
SDS-polyacrylamide gel, followed by Brilliant Blue-G colloidal staining
(Sigma). M, molecular mass marker (Amersham Pharmacia
Biotech) with molecular sizes indicated to the left in
kilodaltons. Arrows indicate the bands due to successful
overexpression at positions corresponding to wild type p48 and
XP2RO-p48 at Mr = 41,000, XP82TO-p48 at
Mr = 42,500, and wild type p127 at
Mr = 127,000.

View larger version (18K):
[in a new window]
Fig. 3.
Purification of DDB p127 and DDB p48
overexpressed in insect cells. A, SDS-PAGE analysis of
DDB p127 fractions visualized by Brilliant Blue-G colloidal staining.
Lane 1, 10 µg of cell-free extract (5210 units);
lane 2, 9-µg phosphocellulose fraction (5440 units);
lane 3, 1.3-µg DEAE fraction (1400 units); lane
4, 1.3-µg S300 fraction (1190 units). B, SDS-PAGE
analysis of DDB p48 fractions. Lane 1, cell-free extract
from uninfected Sf9 cells; lane 2, Sf9 extract
containing overexpressed p48; lane 3, p48 overexpressed in
Sf9 cells and purified through phosphocellulose, DEAE-Sephacel,
and Superose6 columns. p48 is the lower band of the doublet.
M, molecular mass marker (Amersham Pharmacia Biotech) with
molecular sizes indicated to the left in kilodaltons.
CFE, clarified cell-free extract; PC,
phosphocellulose fraction; DE, DEAE-Sephacel fraction;
SC, sizing column fraction.
Purification of DDB p127
Purification of DDB p48
(24). Addition of
overexpressed wild type p48 purified from insect cells restored repair
activity, indicating that p48 is also defective in this XPE
Ddb
strain. Sequence analysis of cDNA prepared from
DDB1 (p127) and DDB2 (p48) mRNA of GM01389 cells identified
compound heterozygous mutations in DDB2, which was confirmed by
sequencing the genomic DNA in the affected region. In one allele, a T
C transition at nucleotide +1049 caused a L350P change, whereas in
the other allele a deletion of nucleotides +1045 to +1047 resulted in
the loss of Asn-349 (Table III). No
mutations were observed in the DDB1 cDNA of the strain. Hence, as
in the three previously identified Ddb
strains, there was
no wild type p48 present.

View larger version (34K):
[in a new window]
Fig. 4.
Wild type p48 restores DDB activity to a
DDB-deficient GM01389 cell-free extract. Binding of DDB in a
clarified GM01389 fibroblast extract to 32P-labeled DNA
substrate was monitored by the electrophoretic mobility shift assay.
Lane 1, 1.5-µg GM01389 cell extract; lane 2,
mixture of 1.5 µg of the GM01389 cell extract and 4 fmol of the DDB
p48 Superose6 fraction; lane 3, 1.5 µg of the XP95TO
(Ddb+) cell extract.
Mutation analysis of DDB2 in XPE Ddb
GM01389 cells
fibroblasts, XP95TO, were
comparable to that observed in the IMR-90 normal fibroblasts (data not
shown). In cell-free extracts from late-log phase IMR-90 fibroblasts,
the induced response of DDB activity to UV irradiation is much slower
than in early- to mid-log phase cells, with only a 2-fold increase
observed at 72 h (data not shown).

View larger version (22K):
[in a new window]
Fig. 5.
Response of p48 mRNA levels, p48 protein,
and DDB activity to UV irradiation. IMR-90 early- to mid-log phase
fibroblasts were irradiated with 12 J/m2 UV light,
incubated in fresh medium, and harvested at the times indicated.
A, the number of viable cells was determined by trypan blue
staining and are expressed relative to the cell number at the time of
irradiation. B, p48 mRNA levels were monitored by
QC-RT-PCR as described under "Experimental Procedures." PCR
products were resolved on a 5% native polyacrylamide gel and
quantitated using a PhosphorImager (Molecular Dynamics) and
ImageQuaNTTM 1.2. C, analysis of the immunoblot in Fig. 6 by
ImageQuaNT. D, 5 µg of cell-free extract and 2 fmol of
32P-labeled UV-irradiated double stranded DNA were used per
reaction. DDB activity was monitored by the electrophoretic mobility
shift assay and quantitated using a PhosphorImager (Molecular Dynamics)
and ImageQuaNT.

View larger version (29K):
[in a new window]
Fig. 6.
DDB p48 is induced by UV irradiation.
IMR-90 early- to mid-log phase fibroblasts were irradiated with 12 J/m2 UV light, incubated in fresh medium, and harvested at
the times indicated. 50 µg of cell-free extract was resolved by 10%
SDS-PAGE, transferred to a nitrocellulose filter, and probed with
polyclonal antibodies raised against His6-p48 polypeptide,
and the filter was analyzed by autoradiography.
XP2RO and XP82TO Do Not
Affect Nuclear Localization of p48--
By fluorescence microscopy,
recombinant GFP-p48 was observed exclusively in the nucleus for wild
type and mutant p48 (Fig. 7). The control
GFP protein alone showed whole cell distribution. This is in agreement
with its small molecular size (26 kDa) and its lack of nuclear
localization signals. Wild type DDB p48 and XP2RO mutant p48 were
strictly localized in the nucleus. This is not surprising, because the
three nuclear localization signals at amino acid positions 2-5 (PKKR),
3-6 (KKRP), and 240-243 (HKKK) are intact in these polypeptides. A
nuclear localization prediction using the PSORT program (web version
6.4 (27)) indicated that there was a 70% certainty that p48 would be
localized to the nucleus. The single amino acid change, K244E, in
XP82TO p48 effectively abolished the third predicted nuclear
localization signal within this mutant p48 but failed to change its
nuclear localization. These results are in agreement with previously
reported studies with T7-tagged p48 immunofluorescence microscopy (28).
However, to rule out the possibility that a requisite factor for p48
nuclear localization is absent in XPE Ddb
cells, GFP-p48
constructs were transfected into XP2RO and XP82TO cells. Mutant and
wild type p48 proteins were still observed in the nucleus (data not
shown).

View larger version (73K):
[in a new window]
Fig. 7.
Nuclear localization of wild type and mutant
p48. Human normal diploid fibroblast IMR-90 cells were transfected
with plasmid DNA coding for GFP alone or GFP-p48 fusions. Cells were
fixed as described under "Experimental Procedures" and stained with
DAPI 24 h after transfection. Fluorescence from DAPI and GFP was
observed under a Zeiss Axiophot fluorescence microscope.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
strains have since been reported
(24). Because the DDB activity is absent in only a subset of XPE
patients, the relationship between XPE and the DDB protein is unclear.
Is the DDB deficiency directly related to nucleotide excision repair?
The fact that microinjection of the DDB heterodimer (p127, p48)
purified from HeLa cells restored unscheduled DNA synthesis to
Ddb
but not Ddb+ cells (17) suggested that
DDB was indeed an "XPE factor." In addition, the high affinity of
DDB for many forms of DNA lesions implied that DDB was a damage
recognition factor for NER.
phenotype. For example. a third
DDB subunit could be defective in all XPE strains.
strains. In addition,
using human p48 overexpressed in and purified from insect cells we were
able to restore DDB activity to extract prepared from a fourth XPE
Ddb
strain, GM01389, which was recently reclassified by
Otrin and coworkers (24). Moreover, mutational analysis of cDNA and
genomic sequences of the DDB2 gene in this strain identified
compound heterozygous mutations: One allele has a L350P change, and the other allele has a deletion of Asn-349. No mutations were found in the
DDB1 gene. Identification of DDB2 mutations in each of these
four XPE Ddb
strains and the functional assays support
the recommendation of Cleaver and colleagues (29) that XPE should be
defined through molecular terms because of difficulties in assignment
by complementation studies. By this definition, XPE would contain only
those cell strains that have a mutation in DDB2.
strains
XP2RO and XP82TO do not affect the nuclear localization of DDB p48.
This observation, combined with the inability of these mutant p48
proteins to complement p127, suggests that the XPE Ddb
mutations affect the direct interaction of the two subunits that is
required for both nuclear localization of the heterodimer and its
subsequent binding to damaged DNA.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Ann Fischer for her expert culturing of cells.
| |
FOOTNOTES |
|---|
* This work was supported by National Institutes of Health Grant P30ES08196, by DOE Contract FG03-92ER61458, and by grants (09670887 and 11770468) from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Division of Biochemistry and Molecular Biology, 401 Barker Hall, University of California, Berkeley, 94720-3202. Tel.: 510-642-7583; Fax: 510-643-9290; E-mail: slinn@socrates.berkeley.edu.
Published, JBC Papers in Press, April, 20, 2000, DOI 10.1074/jbc.M000960200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
XP, xeroderma
pigmentosum;
DDB, damage-specific DNA-binding protein;
Ddb
, absence of DDB activity;
XPE, xeroderma pigmentosum
group E;
NER, nucleotide excision repair;
EMSA, electrophoretic
mobility shift assay;
DTT, dithiothreitol;
PDG, potassium phosphate (pH
7.5), 10% glycerol, 1 mM DTT buffer;
PCR, polymerase chain
reaction;
QC-RT-PCR, quantitative competitive reverse
transcription-PCR;
PAGE, polyacrylamide gel electrophoresis;
DAPI, 4',6-diamidino-2-phenylindole;
PBS, phosphate-buffered saline;
APP, Alzheimer's amyloid precursor protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Cleaver, J. E., and Kraemer, K. H. (1989) in The Metabolic Basis of Inherited Disease (Scriver, C. R. , Beaudet, A. L , Sly, W. S. , and Valle, D., eds), 6th Ed. , pp. 2949-2971, McGraw-Hill, New York |
| 2. | Johnson, R. T., Elliott, G. C., Squires, S., and Joysey, V. C. (1989) Hum. Genet. 81, 203-210 |
| 3. | Chu, G., and Chang, E. (1988) Science 242, 564-567 |
| 4. | Kataoka, H., and Fujiwara, Y. (1991) Biochem. Biophys. Res. Commun. 175, 1139-1143 |
| 5. | Keeney, S., Wein, H., and Linn, S. (1992) Mutat. Res. 273, 49-56 |
| 6. | Feldberg, R. S. (1980) Nucleic Acids Res. 8, 1133-1143 |
| 7. | Carew, J. A., and Feldberg, R. S. (1985) Nucleic Acids Res. 13, 303-315 |
| 8. | Reardon, J. T., Nichols, A. F., Keeney, S., Smith, C. A., Taylor, J.-S., Linn, S., and Sancar, A. (1993) J. Biol. Chem. 268, 21301-21308 |
| 9. | Hirschfeld, S., Levine, A. S., Ozato, K., and Protic, M. A. (1990) Mol. Cell. Biol. 10, 2041-2048 |
| 10. | Keeney, S., Chang, G. J., and Linn, S. (1993) J. Biol. Chem. 268, 21293-21380 |
| 11. | Payne, A., and Chu, G. (1994) Mutat. Res. 310, 89-102 |
| 12. | Protic, M., Hirschfeld, S., Tsang, A. P., Wagner, M., Dixon, K., and Levine, A. S. (1989) Mol. Toxicol. 2, 255-270 |
| 13. | Vaisman, A., and Chaney, S. G. (1995) Biochemistry 34, 105-114 |
| 14. | Mu, D., Park, C. H., Matsunaga, T., Hsu, D. S., Reardon, J. T., and Sancar, A. (1995) J. Biol. Chem. 270, 2415-2418 |
| 15. | Aboussekhra, A., Biggerstaff, M., Shivji, M. K. K., Vilpo, J. A., Moncollin, V, Podust, V. N., Protic, M., Hubscher, U., Egly, J.-M., and Wood, R. D. (1995) Cell 80, 859-868 |
| 16. | Kazantsev, A., Mu, D., Nichols, A. F., Zhao, X., Linn, S., and Sancar, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5014-5018 |
| 17. | Keeney, S., Eker, A. P. M., Brody, T., Vermeulen, W., Bootsma, D., Hoeijmakers, J. H. J., and Linn, S. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 4053-4056 |
| 18. | Nichols, A. F., Ong, P., and Linn, S. (1996) J. Biol. Chem. 271, 24317-24320 |
| 19. | Liu, W., Nichols, A. F., Graham, J. A., Dualan, R., Abbas, A., and Linn, S. (2000) J. Biol. Chem. 275, 21429-21434 |
| 20. | Dualan, R., Brody, T., Keeney, S., Nichols, A. F., Admon, A., and Linn, S. (1995) Genomics 29, 62-69 |
| 21. | Urban, A., Neukirchen, S., and Jaeger, K. E. (1997) Nucleic Acids Res. 25, 2227-2228 |
| 22. | Itoh, T., Mori, T., Ohkubo, H., and Yamaizumi, M. (1999) J. Invest. Dermatol. 113, 251-257 |
| 23. | Borson, N. D., Strausbauch, M. A., Wettstein, P. J., Oda, R. P., Johnston, S. L., and Landers, J. P. (1998) BioTechniques 25, 130-137 |
| 24. | Otrin, V. P., Kuraoka, I., Nardo, T., McLenigan, M., Eker, A. P. M., Stefanini, M., Levine, A. S., and Wood, R. D. (1998) Mol. Cell. Biol. 18, 3182-3190 |
| 25. | Friedberg, E. C., Walker, G. C., and Siede, W. (1995) DNA Repair and Mutagenesis , pp. 285-288, ASM Press, Washington, D.C. |
| 26. | Vaisman, A., Keeney, S., Nichol, A. F., Linn, S., and Chaney, S. G. (1996) Oncol. Res. 9, 7-12 |
| 27. | Nakai, K., and Kanehisa, M. (1992) Genomics 14, 897-911 |
| 28. | Shiyanov, P., Hayes, S. A., Donepudi, M., Nichols, A. F., Linn, S., Slagle, B. L., and Raychaudhuri, P. (1999) Mol. Cell. Biol. 19, 4935-4943 |
| 29. | Cleaver, J. E., Thompson, L. H., Richardson, A. S., and States, J. C. (1999) Hum. Mutat. 14, 9-22 |
| 30. | Lee, T.-H., Elledge, S. J., and Butel, J. S. (1995) J. Virol. 69, 1107-1114 |
| 31. | Becker, S. A., Lee, T.-H., Butel, J. S., and Slagle, B. L. (1998) J. Virol. 72, 266-272 |
| 32. | Lin, G. Y., Paterson, R. G., Richardson, C. D., and Lamb, R. A (1998) Virology 249, 189-200 |
| 33. | Watanabe, T., Sukegawa, J., Sukegawa, I., Tomita, S., Iijima, K., Oguchi, S., Suzuki, N. A. C., and Greengard, P. (1999) J. Neurochem. 72, 549-556 |
| 34. | Hwang, B. J., Toering, S., Francke, U., and Chu, G. (1998) Mol. Cell. Biol. 18, 4391-4399 |
This article has been cited by other articles:
![]() |
T. Stoyanova, T. Yoon, D. Kopanja, M. B. Mokyr, and P. Raychaudhuri The Xeroderma Pigmentosum Group E Gene Product DDB2 Activates Nucleotide Excision Repair by Regulating the Level of p21Waf1/Cip1 Mol. Cell. Biol., January 1, 2008; 28(1): 177 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Vahteristo, A Kokko, O Saksela, K Aittomaki, and L A Aaltonen Blood-derived gene-expression profiling in unravelling susceptibility to recessive disease J. Med. Genet., November 1, 2007; 44(11): 718 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Luijsterburg, J. Goedhart, J. Moser, H. Kool, B. Geverts, A. B. Houtsmuller, L. H. F. Mullenders, W. Vermeulen, and R. van Driel Dynamic in vivo interaction of DDB2 E3 ubiquitin ligase with UV-damaged DNA is independent of damage-recognition protein XPC J. Cell Sci., August 1, 2007; 120(15): 2706 - 2716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, Q.-E. Wang, Q. Zhu, M. A. El-Mahdy, G. Wani, M. Praetorius-Ibba, and A. A. Wani DNA Damage Binding Protein Component DDB1 Participates in Nucleotide Excision Repair through DDB2 DNA-binding and Cullin 4A Ubiquitin Ligase Activity. Cancer Res., September 1, 2006; 66(17): 8590 - 8597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. El-Mahdy, Q. Zhu, Q.-e. Wang, G. Wani, M. Praetorius-Ibba, and A. A. Wani Cullin 4A-mediated Proteolysis of DDB2 Protein at DNA Damage Sites Regulates in Vivo Lesion Recognition by XPC J. Biol. Chem., May 12, 2006; 281(19): 13404 - 13411. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Wittschieben, S. Iwai, and R. D. Wood DDB1-DDB2 (Xeroderma Pigmentosum Group E) Protein Complex Recognizes a Cyclobutane Pyrimidine Dimer, Mismatches, Apurinic/Apyrimidinic Sites, and Compound Lesions in DNA J. Biol. Chem., December 2, 2005; 280(48): 39982 - 39989. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kulaksiz, J. T. Reardon, and A. Sancar Xeroderma Pigmentosum Complementation Group E Protein (XPE/DDB2): Purification of Various Complexes of XPE and Analyses of Their Damaged DNA Binding and Putative DNA Repair Properties Mol. Cell. Biol., November 15, 2005; 25(22): 9784 - 9792. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Sun and C. C.-K. Chao Cross-Resistance to Death Ligand-Induced Apoptosis in Cisplatin-Selected HeLa Cells Associated with Overexpression of DDB2 and Subsequent Induction of cFLIP Mol. Pharmacol., April 1, 2005; 67(4): 1307 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Gadal, A Starzec, C Bozic, C Pillot-Brochet, S Malinge, V Ozanne, J Vicenzi, L Buffat, G Perret, F Iris, et al. Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells J. Mol. Endocrinol., February 1, 2005; 34(1): 61 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Takata, H. Yoshida, M. Yamaguchi, and K. Sakaguchi Drosophila Damaged DNA-Binding Protein 1 Is an Essential Factor for Development Genetics, October 1, 2004; 168(2): 855 - 865. [Abstract] [Full Text] [PDF] |
||||